AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
56.85
-0.43 (-0.75%)
Oct 13, 2026, 3:49 PM EDT - Market open
AtriCure Revenue
AtriCure had revenue of $153.60M in the quarter ending June 30, 2026, with 12.83% growth. This brings the company's revenue in the last twelve months to $569.62M, up 13.94% year-over-year. In the year 2025, AtriCure had annual revenue of $534.53M with 14.88% growth. That makes AtriCure the 10,488th largest company in the world by revenue and 2,216th in the United States.
Revenue (ttm)
$569.62M
Revenue Growth
+13.94%
P/S Ratio
5.06
Revenue / Employee
$421,942
Employees
1,350
Market Cap
2.89B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 534.53M | 69.22M | 14.88% |
| Dec 31, 2024 | 465.31M | 66.06M | 16.55% |
| Dec 31, 2023 | 399.25M | 68.87M | 20.84% |
| Dec 31, 2022 | 330.38M | 56.05M | 20.43% |
| Dec 31, 2021 | 274.33M | 67.80M | 32.83% |
| Dec 31, 2020 | 206.53M | -24.28M | -10.52% |
| Dec 31, 2019 | 230.81M | 29.18M | 14.47% |
| Dec 31, 2018 | 201.63M | 26.91M | 15.40% |
| Dec 31, 2017 | 174.72M | 19.61M | 12.64% |
| Dec 31, 2016 | 155.11M | 25.35M | 19.54% |
| Dec 31, 2015 | 129.76M | 22.30M | 20.75% |
| Dec 31, 2014 | 107.45M | 25.57M | 31.22% |
| Dec 31, 2013 | 81.89M | 11.64M | 16.57% |
| Dec 31, 2012 | 70.25M | 5.85M | 9.08% |
| Dec 31, 2011 | 64.40M | 5.40M | 9.14% |
| Dec 31, 2010 | 59.01M | 4.47M | 8.20% |
| Dec 31, 2009 | 54.53M | -723.47K | -1.31% |
| Dec 31, 2008 | 55.26M | 6.95M | 14.38% |
| Dec 31, 2007 | 48.31M | 10.07M | 26.32% |
| Dec 31, 2006 | 38.24M | 7.29M | 23.54% |
| Dec 31, 2005 | 30.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.64B |
| Envista Holdings | 2.86B |
| Teleflex | 2.25B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.58B |
| Stevanato Group | 1.40B |
| Warby Parker | 911.61M |
| Azenta | 613.81M |
ATRC News
- 7 hours ago - AtriCure to Announce Third Quarter 2026 Financial Results - Business Wire
- 1 day ago - AtriCure price target raised to $63 from $55 at BTIG - TheFly
- 11 days ago - AtriCure downgraded to Hold from Buy at Freedom Capital - TheFly
- 5 weeks ago - AtriCure Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 6 weeks ago - AtriCure price target raised to $60 from $50 at Piper Sandler - TheFly
- 7 weeks ago - AtriCure to Participate in the 2026 Wells Fargo Health Care Conference - Business Wire
- 7 weeks ago - AtriCure price target raised to $55 from $45 at BTIG - TheFly
- 2 months ago - AtriCure Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts